Abstract: Provided is a novel compound and a use thereof. A novel compound according to the presently claimed subject matter induces the activation of MKP-1 protein to block the cellular signaling pathway proceeding in the order of p38/CK2?/NF-?B, thereby very effectively inhibiting an inflammatory response occurring in a respiratory disease. Therefore, a respiratory disease can be prevented, alleviated, or treated by orally administering the novel compound according to the presently claimed subject matter.
Type:
Application
Filed:
November 24, 2020
Publication date:
January 26, 2023
Applicant:
MICROX CO., LTD.
Inventors:
Hern Ku LEE, Myung Kwan HAN, Ki Bum HONG, Ji Hoon LEE, Ji Hoon YU, Jusuk LEE, Shun Young IM, Hwa Ryung SONG